Medfield Diagnostics AB (publ) aims to facilitate the diagnosis of stroke. Early diagnosis of stroke, if it due to a bleeding or a blood clot, will enable faster treatment than today possible.

This eliminates suffering of affected patients as well as cost savings due to reduced healthcare and rehabilitation costs. Medfield is during the period February 20 to March 27 offering a new issue of shares followed by listing on AktieTorget. More information about the offer can be found under investors (Swedish only).